$DJT
Trump Media & Technology Group Corp.

2024 Q2 Form 10-Q Financial Statement

#000114036124026889 Filed on May 20, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q4
Revenue $836.9K $770.5K $0.00
YoY Change
Cost Of Revenue $36.20K $93.40K $164.9K
YoY Change -12.14% 126.15%
Gross Profit $800.7K $677.1K $3.966M
YoY Change -30.43% -37.01%
Gross Profit Margin 95.67% 87.88%
Selling, General & Admin $13.42M $64.80M $113.8K
YoY Change 29.15% 9570.91%
% of Gross Profit 1675.86% 9569.5% 2.87%
Research & Development $4.862M $33.16M $9.716M
YoY Change 121.24% 1079.14%
% of Gross Profit 607.17% 4897.15% 244.96%
Depreciation & Amortization $3.700K $5.600K $60.40K
YoY Change -77.98% -66.06%
% of Gross Profit 0.46% 0.83% 1.52%
Operating Expenses $18.28M $97.95M $4.505M
YoY Change 54.79% 9503.3% -36.38%
Operating Profit -$18.66M -$98.35M -$539.1K
YoY Change 58.01% 9508.7%
Interest Expense -$157.8K $2.818M $3.448M
YoY Change -104.36% -11.67% 37.63%
% of Operating Profit
Other Income/Expense, Net $34.59K
YoY Change
Pretax Income -$16.37M -$327.6M -$1.023M
YoY Change 99.87% -15245.06% -77.64%
Income Tax $0.00 $0.00 $861.1K
% Of Pretax Income
Net Earnings -$16.37M -$327.6M -$9.178M
YoY Change 79.99% -25698.01% 76.55%
Net Earnings / Revenue -1955.79% -42517.81%
Basic Earnings Per Share -$0.10 -$3.61
Diluted Earnings Per Share -$0.10 -$3.61 -$0.05
COMMON SHARES
Basic Shares Outstanding 176.7M 136.7M
Diluted Shares Outstanding 166.7M 90.74M

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $344.0M $233.7M $395.0K
YoY Change 343854.4% 116750.45% 39800.0%
Cash & Equivalents $344.0M $233.7M $395.0K
Short-Term Investments
Other Short-Term Assets $9.553M $40.35M $0.00
YoY Change 9453.4% 20076.5% -100.0%
Inventory
Prepaid Expenses $0.00
Receivables $17.50K $47.20K $81.00K
Other Receivables $0.00 $0.00
Total Short-Term Assets $353.5M $274.1M $395.0K
YoY Change 220123.82% 87155.83% 133.27%
LONG-TERM ASSETS
Property, Plant & Equipment $2.162M $23.70K $29.20K
YoY Change
Goodwill $0.00
YoY Change
Intangibles $0.00
YoY Change
Long-Term Investments $310.6M
YoY Change 3.43%
Other Assets
YoY Change
Total Long-Term Assets $2.969M $337.5K $310.6M
YoY Change -99.03% -99.89% 3.43%
TOTAL ASSETS
Total Short-Term Assets $353.5M $274.1M $395.0K
Total Long-Term Assets $2.969M $337.5K $310.6M
Total Assets $356.5M $274.4M $311.0M
YoY Change 16.01% -9.67% 3.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.948M $1.148M $1.601M
YoY Change
Accrued Expenses $3.293M $3.293M $47.10M
YoY Change -88.87% -82.22% 174.39%
Deferred Revenue $2.925M $3.717M $4.413M
YoY Change
Short-Term Debt $0.00 $0.00 $6.783M
YoY Change -100.0% -100.0% 93.75%
Long-Term Debt Due $0.00 $50.16M $0.00
YoY Change
Total Short-Term Liabilities $14.30M $64.00M $56.18M
YoY Change -62.04% 150.88% 149.98%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $530.3K $159.8K $10.06M
YoY Change -94.75% -98.42% 0.0%
Total Long-Term Liabilities $530.3K $159.8K $10.06M
YoY Change -94.75% -98.42% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $14.30M $64.00M $56.18M
Total Long-Term Liabilities $530.3K $159.8K $10.06M
Total Liabilities $14.83M $64.16M $66.24M
YoY Change -68.93% 80.36% 103.59%
SHAREHOLDERS EQUITY
Retained Earnings -$2.888B -$2.872B -$63.87M
YoY Change 6433.02% 8638.13% 106.11%
Common Stock $3.230B $3.082B $8.800K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $0.00
YoY Change
Treasury Stock Shares
Shareholders Equity $341.7M $210.3M -$63.87M
YoY Change
Total Liabilities & Shareholders Equity $356.5M $274.4M $311.0M
YoY Change 16.01% -9.67% 3.5%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income -$16.37M -$327.6M -$9.178M
YoY Change 79.99% -25698.01% 76.55%
Depreciation, Depletion And Amortization $3.700K $5.600K $60.40K
YoY Change -77.98% -66.06%
Cash From Operating Activities -$21.44M -$9.316M -$3.433M
YoY Change 10619.15% 2148.69% 630.56%
INVESTING ACTIVITIES
Capital Expenditures $2.142M $0.00 $2.200K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$2.142M $0.00 $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 93.81M 280.5M 542.0K
YoY Change 78071.17% 49453.45% 31.9%
NET CHANGE
Cash From Operating Activities -21.44M -9.316M -3.433M
Cash From Investing Activities -2.142M 0.000 0.000
Cash From Financing Activities 93.81M 280.5M 542.0K
Net Change In Cash 70.23M 271.2M -2.891M
YoY Change -87881.5% 178628.73% 14452800.0%
FREE CASH FLOW
Cash From Operating Activities -$21.44M -$9.316M -$3.433M
Capital Expenditures $2.142M $0.00 $2.200K
Free Cash Flow -$23.58M -$9.316M -$3.435M
YoY Change 2148.69%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001849635
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2024Q1 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#Assets
CY2023Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#Assets
CY2023Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#LiabilitiesCurrent
CY2024Q1 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#LiabilitiesCurrent
CY2023Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#Liabilities
CY2024Q1 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#Liabilities
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
40028300
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
0
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-210300
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.61
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.61
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
770500
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1116200
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
93400
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
41300
CY2024Q1 us-gaap Gross Profit
GrossProfit
677100
CY2023Q1 us-gaap Gross Profit
GrossProfit
1074900
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
33158600
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2812100
CY2024Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1070400
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
256100
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
64795100
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1836300
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5600
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
16300
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
99029700
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
4920800
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-98352600
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3845900
CY2024Q1 us-gaap Interest Expense
InterestExpense
2817600
CY2023Q1 us-gaap Interest Expense
InterestExpense
2024300
CY2024Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
28800
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
0
CY2024Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-542300
CY2023Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2024Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-225916000
CY2023Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
5659900
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-327599700
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-210300
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-327599700
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
90743994
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
87500000
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
90743994
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
87500000
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
84588000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
0
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-8572500
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-210300
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-8782800
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-22768100
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-31550900
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-26033100
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-57584000
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-9177900
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-66761900
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-327599700
CY2024Q1 djt Adjustments To Additional Paid In Capital Fair Value Earnout Shares
AdjustmentsToAdditionalPaidInCapitalFairValueEarnoutShares
0
CY2024Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
300426000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
84588000
CY2024Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
219621600
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
210274000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-327599700
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-210300
CY2024Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
2817600
CY2023Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
2024300
CY2024Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
225916000
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-5659900
CY2024Q1 us-gaap Depreciation
Depreciation
5600
CY2023Q1 us-gaap Depreciation
Depreciation
16500
CY2024Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-542300
CY2023Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
84588000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
0
CY2024Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
400
CY2023Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1800
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2800
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
0
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-33800
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-13200
CY2024Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-695900
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
0
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
5073100
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
39900
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9316000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3774500
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0
CY2024Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
47455000
CY2023Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0
CY2024Q1 djt Proceeds From Merger Related Costs Financing Activities
ProceedsFromMergerRelatedCostsFinancingActivities
233017500
CY2023Q1 djt Proceeds From Merger Related Costs Financing Activities
ProceedsFromMergerRelatedCostsFinancingActivities
0
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
280472500
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
271156500
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-3774500
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2572700
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9808400
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
273729200
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6033900
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
233700900
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6033900
CY2024Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
40028300
CY2023Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
0
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
273729200
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6033900
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
0
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
0
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0
CY2024Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
300426000
CY2023Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
0
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12577300
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9316000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3774500
CY2024Q1 us-gaap Assets Current
AssetsCurrent
274101100
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
64004800
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">Use of Estimates</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates. Material estimates and assumptions reflected in the unaudited condensed  consolidated financial statements relate to and include, but are not limited to, the valuation of convertible promissory notes and derivative liabilities.</div>
CY2024Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-695900
CY2024Q1 djt Deferred Revenue Reorganization Period
DeferredRevenueReorganizationPeriod
P12M
CY2024Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1070400
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
256100
CY2024Q1 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
131700
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
126100
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
23700
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
29200
CY2024Q1 us-gaap Depreciation
Depreciation
5600
CY2023Q1 us-gaap Depreciation
Depreciation
16500
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
313800
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
353200
CY2024Q1 djt Lease Right Of Use Asset
LeaseRightOfUseAsset
313800
CY2023Q4 djt Lease Right Of Use Asset
LeaseRightOfUseAsset
353200
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
163100
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
160300
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
159800
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
201600
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
322900
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
361900
CY2024Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
44800
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
44800
CY2024Q1 us-gaap Lease Cost
LeaseCost
44800
CY2023 us-gaap Lease Cost
LeaseCost
44800
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
136100
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
185800
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
31300
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
353200
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
30300
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
322900
CY2024Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
98258000
CY2023Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
40700000
CY2024Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
240000
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
240000
CY2024Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
98018000
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
40460000
CY2024Q1 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
37234800
CY2023Q4 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
37234800
CY2024Q1 djt Debt Instrument Liability Component
DebtInstrumentLiabilityComponent
60783200
CY2023Q4 djt Debt Instrument Liability Component
DebtInstrumentLiabilityComponent
3225200
CY2024Q1 djt Debt Instrument Aggregate Interest Charged
DebtInstrumentAggregateInterestCharged
44939400
CY2023Q4 djt Debt Instrument Aggregate Interest Charged
DebtInstrumentAggregateInterestCharged
42121800
CY2024Q1 djt Gain Losses On Extinguishment Of Debt
GainLossesOnExtinguishmentOfDebt
-542300
CY2023Q4 djt Gain Losses On Extinguishment Of Debt
GainLossesOnExtinguishmentOfDebt
0
CY2024Q1 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
106264900
CY2023Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
45347000
CY2024Q1 djt Debt Instrument Conversion Of Debt Into Paid In Capital
DebtInstrumentConversionOfDebtIntoPaidInCapital
56107100
CY2023Q4 djt Debt Instrument Conversion Of Debt Into Paid In Capital
DebtInstrumentConversionOfDebtIntoPaidInCapital
0
CY2024Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
50157800
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
42415500
CY2024Q1 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0
CY2023Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
2931500
CY2024Q1 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
37234800
CY2023Q4 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
37234800
CY2024Q1 djt Aggregate Change In Fair Value Of Embedded Derivative
AggregateChangeInFairValueOfEmbeddedDerivative
-207084100
CY2023Q4 djt Aggregate Change In Fair Value Of Embedded Derivative
AggregateChangeInFairValueOfEmbeddedDerivative
18832000
CY2024Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
244318900
CY2023Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
18402800
CY2024Q1 djt Derivative Liability Conversion Paid In Capital
DerivativeLiabilityConversionPaidInCapital
244318900
CY2023Q4 djt Derivative Liability Conversion Paid In Capital
DerivativeLiabilityConversionPaidInCapital
0
CY2024Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
17282500
CY2024Q1 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
0
CY2023Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
1120300
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
50157800
CY2024Q1 us-gaap Capital Units Authorized
CapitalUnitsAuthorized
1000000000
CY2024Q1 djt Capital Stock Par Or Stated Value Per Share
CapitalStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
27741229
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2024Q1 djt Number Of Shares Deposited Into Escrow Account
NumberOfSharesDepositedIntoEscrowAccount
4667033
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
11000
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.000001
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10000
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
110000000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.000001
CY2021Q4 djt Common Stock Shares Reclassified
CommonStockSharesReclassified
10000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.000001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
110000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
100000000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
100000000
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.000001
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
100000000
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
100000000
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.000001
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
100000000
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
100000000
CY2024Q1 djt Number Of Shares Deposited Into Escrow Account
NumberOfSharesDepositedIntoEscrowAccount
4667033
CY2023Q3 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
18000000
CY2024Q1 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
18000000
CY2023Q4 djt Loss Contingency Period Of Plaintiff Allegation
LossContingencyPeriodOfPlaintiffAllegation
P6M
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false

Files In Submission

Name View Source Status
0001140361-24-026889-index-headers.html Edgar Link pending
0001140361-24-026889-index.html Edgar Link pending
0001140361-24-026889.txt Edgar Link pending
0001140361-24-026889-xbrl.zip Edgar Link pending
djt-20240331.xsd Edgar Link pending
ef20028790_10q.htm Edgar Link pending
ef20028790_ex31-1.htm Edgar Link pending
ef20028790_ex31-2.htm Edgar Link pending
ef20028790_ex32-1.htm Edgar Link pending
ef20028790_ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
djt-20240331_def.xml Edgar Link unprocessable
djt-20240331_lab.xml Edgar Link unprocessable
djt-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ef20028790_10q_htm.xml Edgar Link completed
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
djt-20240331_cal.xml Edgar Link unprocessable